150 related articles for article (PubMed ID: 3202888)
1. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
Broggini M; Grandi M; Ubezio P; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1988 Dec; 37(23):4423-31. PubMed ID: 3202888
[TBL] [Abstract][Full Text] [Related]
2. DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells.
Capolongo L; Belvedere G; D'Incalci M
Cancer Chemother Pharmacol; 1990; 25(6):430-4. PubMed ID: 2311171
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
Mannironi C; D'Incalci M
Biochem Biophys Res Commun; 1988 Sep; 155(3):1221-9. PubMed ID: 3178805
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
5. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
[TBL] [Abstract][Full Text] [Related]
6. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
7. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
8. Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cells.
Silvestrini R; Zaffaroni N; Costa A; Orlandi L; Villa R; Hendriks HR
Int J Cancer; 1993 Oct; 55(4):636-9. PubMed ID: 8406992
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo).
Belvedere G; Suarato A; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1989 Nov; 38(21):3713-21. PubMed ID: 2557027
[TBL] [Abstract][Full Text] [Related]
10. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
Bellamy WT; Dorr RT; Dalton WS; Alberts DS
Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.
La Porta CA; Dolfini E; Comolli R
Br J Cancer; 1998 Nov; 78(10):1283-7. PubMed ID: 9823967
[TBL] [Abstract][Full Text] [Related]
12. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
[TBL] [Abstract][Full Text] [Related]
13. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.
Supino R; Mariani M; Capranico G; Colombo A; Parmiani G
Br J Cancer; 1988 Feb; 57(2):142-6. PubMed ID: 3358904
[TBL] [Abstract][Full Text] [Related]
15. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
[TBL] [Abstract][Full Text] [Related]
16. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A; Revelli S; Tamponi G; Giorgianni A; Todde R; Bosia A; Ghigo D
Cell Biochem Funct; 1996 Mar; 14(1):11-8. PubMed ID: 8907249
[TBL] [Abstract][Full Text] [Related]
17. D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
Damiani D; Michieli M; Michelutti A; Melli C; Cerno M; Baccarani M
Anticancer Drugs; 1993 Apr; 4(2):173-80. PubMed ID: 8098233
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine as a modulator of resistance to doxorubicin in human colon-adenocarcinoma cells.
Bearzatto A; Saino A; Zaffaroni N; Costa A; Santi S
Int J Oncol; 1996 Jul; 9(1):57-63. PubMed ID: 21541481
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts.
Calcabrini A; Arancia G; Marra M; Crateri P; Befani O; Martone A; Agostinelli E
Int J Cancer; 2002 May; 99(1):43-52. PubMed ID: 11948490
[TBL] [Abstract][Full Text] [Related]
20. Effect of new oxicam derivatives on efflux pumps overexpressed in resistant a human colorectal adenocarcinoma cell line.
Środa-Pomianek K; Wesołowska O; Szczęśniak-Sięga B; Puła B; Dzięgiel P; Maniewska J; Malinka W; Palko-Łabuz A; Michalak K
Anticancer Res; 2015 May; 35(5):2835-40. PubMed ID: 25964564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
